[
    [
        {
            "time": "2023-03-15",
            "original_text": "Pharma Stock Roundup: New Warning Order by FDA for JAK Drugs, & Pipeline Updates",
            "features": {
                "keywords": [
                    "Pharma",
                    "FDA",
                    "Warning",
                    "JAK Drugs",
                    "Pipeline Updates"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Pharma Stock Roundup: New Warning Order by FDA for JAK Drugs, & Pipeline Updates",
                "Correlation": 8,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-03-15",
            "original_text": "Are Investors Undervaluing AbbVie Inc. (NYSE:ABBV) By 48%?",
            "features": {
                "keywords": [
                    "Investors",
                    "Undervaluing",
                    "AbbVie",
                    "NYSE:ABBV"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Are Investors Undervaluing AbbVie Inc. (NYSE:ABBV) By 48%?",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]